Farhad Hafezi

MD, PhD, Laboratory for Ocular Cell Biology, University of Geneva, Geneva, Switzerland; Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; ELZA Institute, Zurich, Switzerland.

Latest Contribution

PACK-crosslinking for infectious keratitis

1 October 2015 | | Cornea / External Eye Disease

Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...